399 related articles for article (PubMed ID: 15820813)
21. Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy.
Seeber BE; Sammel MD; Guo W; Zhou L; Hummel A; Barnhart KT
Fertil Steril; 2006 Aug; 86(2):454-9. PubMed ID: 16753158
[TBL] [Abstract][Full Text] [Related]
22. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
Papapetrou PD; Anagnostopoulos NI
J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023
[TBL] [Abstract][Full Text] [Related]
23. First-trimester rapid semiquantitative assay for urine pregnanediol glucuronide predicts gestational outcome with the same diagnostic accuracy as serial human chorionic gonadotropin measurements.
Long CA; Whitworth NS; Murthy HM; Bacquet K; Cowan BD
Am J Obstet Gynecol; 1994 Jun; 170(6):1822-5; discussion 1825-7. PubMed ID: 8203444
[TBL] [Abstract][Full Text] [Related]
24. Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy.
McChesney R; Wilcox AJ; O'Connor JF; Weinberg CR; Baird DD; Schlatterer JP; McConnaughey DR; Birken S; Canfield RE
Hum Reprod; 2005 Apr; 20(4):928-35. PubMed ID: 15665026
[TBL] [Abstract][Full Text] [Related]
25. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility.
Randall GW; Gantt PA
J Reprod Med; 2008 Mar; 53(3):196-202. PubMed ID: 18441725
[TBL] [Abstract][Full Text] [Related]
26. Production of human chorionic gonadotropin during the normal menstrual cycle.
Cole LA; Gutierrez JM
J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
[TBL] [Abstract][Full Text] [Related]
27. Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
Qiu Q; Overstreet JW; Todd H; Nakajima ST; Stewart DR; Lasley BL
Environ Health Perspect; 1997 Aug; 105(8):862-6. PubMed ID: 9347902
[TBL] [Abstract][Full Text] [Related]
28. Subclinical spontaneous abortion.
Braunstein GD; Karow WG; Gentry WD; Wade ME
Obstet Gynecol; 1977 Jul; 50(1 Suppl):41s-44s. PubMed ID: 876540
[TBL] [Abstract][Full Text] [Related]
29. The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study.
Cantineau AE; Cohlen BJ;
Fertil Steril; 2007 Jul; 88(1):107-12. PubMed ID: 17445811
[TBL] [Abstract][Full Text] [Related]
30. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
31. Individual deviations in human chorionic gonadotropin concentrations during pregnancy.
Cole LA
Am J Obstet Gynecol; 2011 Apr; 204(4):349.e1-7. PubMed ID: 21324434
[TBL] [Abstract][Full Text] [Related]
32. Prospective assessment of early fetal loss using an immunoenzymometric screening assay for detection of urinary human chorionic gonadotropin.
Taylor CA; Overstreet JW; Samuels SJ; Boyers SP; Canfield RE; O'Connor JF; Hanson FW; Lasley BL
Fertil Steril; 1992 Jun; 57(6):1220-4. PubMed ID: 1601143
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of methods for the prospective identification of early fetal losses in environmental epidemiology studies.
Sweeney AM; Meyer MR; Aarons JH; Mills JL; LaPorte RE
Am J Epidemiol; 1988 Apr; 127(4):843-50. PubMed ID: 3354549
[TBL] [Abstract][Full Text] [Related]
34. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
35. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
36. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation.
Lofrano-Porto A; Casulari LA; Nascimento PP; Giacomini L; Naves LA; da Motta LD; Layman LC
Fertil Steril; 2008 Oct; 90(4):1169-74. PubMed ID: 17961559
[TBL] [Abstract][Full Text] [Related]
37. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications.
Kovalevskaya G; Kakuma T; Schlatterer J; O'Connor JF
Mol Cell Endocrinol; 2007 Jan; 260-262():237-43. PubMed ID: 17092638
[TBL] [Abstract][Full Text] [Related]
38. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
[TBL] [Abstract][Full Text] [Related]
39. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
[TBL] [Abstract][Full Text] [Related]
40. Chemical abortion in patients with recurrent fetal loss.
Oka C; Makino T; Itakura I; Hara T; Nozawa S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):239-40. PubMed ID: 1707432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]